Similar articles for PMID: 23017138

Year	Number of Results
2004	1
2005	4
2006	3
2007	9
2008	5
2009	5
2010	5
2011	7
2012	15
2013	5
2014	6
2015	6
2016	5
2017	5
2018	5
2019	7
2020	7
2021	7
2022	1
2024	0

1

Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives.

Raber P, Ochoa AC, Rodríguez PC. Raber P, et al. Immunol Invest. 2012;41(6-7):614-34. doi: 10.3109/08820139.2012.680634. Immunol Invest. 2012. PMID: 23017138 Free PMC article. Review.

2

Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives.

Rodríguez PC, Ochoa AC. Rodríguez PC, et al. Immunol Rev. 2008 Apr;222:180-91. doi: 10.1111/j.1600-065X.2008.00608.x. Immunol Rev. 2008. PMID: 18364002 Free PMC article. Review.

3

PGE(2)-driven induction and maintenance of cancer-associated myeloid-derived suppressor cells.

Obermajer N, Wong JL, Edwards RP, Odunsi K, Moysich K, Kalinski P. Obermajer N, et al. Immunol Invest. 2012;41(6-7):635-57. doi: 10.3109/08820139.2012.695417. Immunol Invest. 2012. PMID: 23017139 Review.

4

Negative regulation of myeloid-derived suppressor cells in cancer.

Qu P, Boelte KC, Lin PC. Qu P, et al. Immunol Invest. 2012;41(6-7):562-80. doi: 10.3109/08820139.2012.685538. Immunol Invest. 2012. PMID: 23017135 Free PMC article. Review.

5

Immune suppression: the hallmark of myeloid derived suppressor cells.

Haile LA, Greten TF, Korangy F. Haile LA, et al. Immunol Invest. 2012;41(6-7):581-94. doi: 10.3109/08820139.2012.680635. Immunol Invest. 2012. PMID: 23017136 Free PMC article. Review.

6

Highlights on molecular mechanisms of MDSC-mediated immune suppression: paving the way for new working hypotheses.

Solito S, Pinton L, Damuzzo V, Mandruzzato S. Solito S, et al. Immunol Invest. 2012;41(6-7):722-37. doi: 10.3109/08820139.2012.678023. Immunol Invest. 2012. PMID: 23017143 Review.

7

Myeloid Cell-Derived Arginase in Cancer Immune Response.

Grzywa TM, Sosnowska A, Matryba P, Rydzynska Z, Jasinski M, Nowis D, Golab J. Grzywa TM, et al. Front Immunol. 2020 May 15;11:938. doi: 10.3389/fimmu.2020.00938. eCollection 2020. Front Immunol. 2020. PMID: 32499785 Free PMC article. Review.

8

Arginase-1 is neither constitutively expressed in nor required for myeloid-derived suppressor cell-mediated inhibition of T-cell proliferation.

Bian Z, Abdelaal AM, Shi L, Liang H, Xiong L, Kidder K, Venkataramani M, Culpepper C, Zen K, Liu Y. Bian Z, et al. Eur J Immunol. 2018 Jun;48(6):1046-1058. doi: 10.1002/eji.201747355. Epub 2018 Mar 23. Eur J Immunol. 2018. PMID: 29488625 Free PMC article.

9

Myeloid-derived suppressor cells reveal radioprotective properties through arginase-induced l-arginine depletion.

Leonard W, Dufait I, Schwarze JK, Law K, Engels B, Jiang H, Van den Berge D, Gevaert T, Storme G, Verovski V, Breckpot K, De Ridder M. Leonard W, et al. Radiother Oncol. 2016 May;119(2):291-9. doi: 10.1016/j.radonc.2016.01.014. Epub 2016 Feb 10. Radiother Oncol. 2016. PMID: 26874542

10

Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment.

Steggerda SM, Bennett MK, Chen J, Emberley E, Huang T, Janes JR, Li W, MacKinnon AL, Makkouk A, Marguier G, Murray PJ, Neou S, Pan A, Parlati F, Rodriguez MLM, Van de Velde LA, Wang T, Works M, Zhang J, Zhang W, Gross MI. Steggerda SM, et al. J Immunother Cancer. 2017 Dec 19;5(1):101. doi: 10.1186/s40425-017-0308-4. J Immunother Cancer. 2017. PMID: 29254508 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

96 results

Results by year